255 related articles for article (PubMed ID: 33536206)
1. Laminin γ2-mediating T cell exclusion attenuates response to anti-PD-1 therapy.
Li L; Wei JR; Dong J; Lin QG; Tang H; Jia YX; Tan W; Chen QY; Zeng TT; Xing S; Qin YR; Zhu YH; Li Y; Guan XY
Sci Adv; 2021 Feb; 7(6):. PubMed ID: 33536206
[TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptomics reveals the effect of PD-L1/TGF-β blockade on the tumor microenvironment.
Lim YW; Coles GL; Sandhu SK; Johnson DS; Adler AS; Stone EL
BMC Biol; 2021 May; 19(1):107. PubMed ID: 34030676
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor gene amplification is correlated with laminin-5 gamma2 chain expression in oral squamous cell carcinoma cell lines.
Ono Y; Nakanishi Y; Gotoh M; Sakamoto M; Hirohashi S
Cancer Lett; 2002 Jan; 175(2):197-204. PubMed ID: 11741748
[TBL] [Abstract][Full Text] [Related]
4. Dual TGF-β and PD-1 blockade synergistically enhances MAGE-A3-specific CD8
Chen X; Wang L; Li P; Song M; Qin G; Gao Q; Zhang Z; Yue D; Wang D; Nan S; Qi Y; Li F; Yang L; Huang L; Zhang M; Zhang B; Gao Y; Zhang Y
Int J Cancer; 2018 Nov; 143(10):2561-2574. PubMed ID: 29981155
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid laminin-5 gamma2 chain levels in chronic periodontitis.
Emingil G; Atilla G; Sorsa T; Savolainen P; Baylas H
J Periodontol; 2004 Oct; 75(10):1387-96. PubMed ID: 15562917
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta orchestrates PD-L1 enrichment in tumor-derived exosomes and mediates CD8 T-cell dysfunction regulating early phosphorylation of TCR signalome in breast cancer.
Chatterjee S; Chatterjee A; Jana S; Dey S; Roy H; Das MK; Alam J; Adhikary A; Chowdhury A; Biswas A; Manna D; Bhattacharyya A
Carcinogenesis; 2021 Feb; 42(1):38-47. PubMed ID: 32832992
[TBL] [Abstract][Full Text] [Related]
7. Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade.
Holmgaard RB; Schaer DA; Li Y; Castaneda SP; Murphy MY; Xu X; Inigo I; Dobkin J; Manro JR; Iversen PW; Surguladze D; Hall GE; Novosiadly RD; Benhadji KA; Plowman GD; Kalos M; Driscoll KE
J Immunother Cancer; 2018 Jun; 6(1):47. PubMed ID: 29866156
[TBL] [Abstract][Full Text] [Related]
8. Combined Blockade of GARP:TGF-β1 and PD-1 Increases Infiltration of T Cells and Density of Pericyte-Covered GARP
Bertrand C; Van Meerbeeck P; de Streel G; Vaherto-Bleeckx N; Benhaddi F; Rouaud L; Noël A; Coulie PG; van Baren N; Lucas S
Front Immunol; 2021; 12():704050. PubMed ID: 34386010
[TBL] [Abstract][Full Text] [Related]
9. Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review.
Yasuda H; Nakagawa M; Kiyokawa H; Yoshida E; Yoshimura T; Koshikawa N; Itoh F; Seiki M
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626121
[TBL] [Abstract][Full Text] [Related]
10. Urinary laminin-γ2 is a novel biomarker of non-muscle invasive urothelial carcinoma.
Kamada M; Koshikawa N; Minegishi T; Kawada C; Karashima T; Shuin T; Seiki M
Cancer Sci; 2015 Dec; 106(12):1730-7. PubMed ID: 26450632
[TBL] [Abstract][Full Text] [Related]
11. Correlation between laminin-5 gamma2 chain expression and epidermal growth factor receptor expression and its clinicopathological significance in squamous cell carcinoma of the tongue.
Katoh K; Nakanishi Y; Akimoto S; Yoshimura K; Takagi M; Sakamoto M; Hirohashi S
Oncology; 2002; 62(4):318-26. PubMed ID: 12138239
[TBL] [Abstract][Full Text] [Related]
12. Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances.
Lind H; Gameiro SR; Jochems C; Donahue RN; Strauss J; Gulley JL; Palena C; Schlom J
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32079617
[TBL] [Abstract][Full Text] [Related]
13. Correlation between laminin-5 gamma2 chain and epidermal growth factor receptor expression in esophageal squamous cell carcinomas.
Fukai Y; Masuda N; Kato H; Fukuchi M; Miyazaki T; Nakajima M; Sohda M; Kuwano H; Nakajima T
Oncology; 2005; 69(1):71-80. PubMed ID: 16103736
[TBL] [Abstract][Full Text] [Related]
14. TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Mariathasan S; Turley SJ; Nickles D; Castiglioni A; Yuen K; Wang Y; Kadel EE; Koeppen H; Astarita JL; Cubas R; Jhunjhunwala S; Banchereau R; Yang Y; Guan Y; Chalouni C; Ziai J; Şenbabaoğlu Y; Santoro S; Sheinson D; Hung J; Giltnane JM; Pierce AA; Mesh K; Lianoglou S; Riegler J; Carano RAD; Eriksson P; Höglund M; Somarriba L; Halligan DL; van der Heijden MS; Loriot Y; Rosenberg JE; Fong L; Mellman I; Chen DS; Green M; Derleth C; Fine GD; Hegde PS; Bourgon R; Powles T
Nature; 2018 Feb; 554(7693):544-548. PubMed ID: 29443960
[TBL] [Abstract][Full Text] [Related]
15. [Blood concentration of laminin gamma2 chain in patients with head and neck cancer].
Kuratomi Y; Katayama M; Kidera K; Hayashida S; Satoh S; Monji M; Shimazu R; Ayada T; Toh S; Inokuchi A
Nihon Jibiinkoka Gakkai Kaiho; 2006 Jun; 109(6):517-23. PubMed ID: 16838673
[TBL] [Abstract][Full Text] [Related]
16. Aptamer targeted therapy potentiates immune checkpoint blockade in triple-negative breast cancer.
Camorani S; Passariello M; Agnello L; Esposito S; Collina F; Cantile M; Di Bonito M; Ulasov IV; Fedele M; Zannetti A; De Lorenzo C; Cerchia L
J Exp Clin Cancer Res; 2020 Sep; 39(1):180. PubMed ID: 32892748
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer.
de Streel G; Bertrand C; Chalon N; Liénart S; Bricard O; Lecomte S; Devreux J; Gaignage M; De Boeck G; Mariën L; Van De Walle I; van der Woning B; Saunders M; de Haard H; Vermeersch E; Maes W; Deckmyn H; Coulie PG; van Baren N; Lucas S
Nat Commun; 2020 Sep; 11(1):4545. PubMed ID: 32917858
[TBL] [Abstract][Full Text] [Related]
18. Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models.
Sow HS; Ren J; Camps M; Ossendorp F; Ten Dijke P
Cells; 2019 Apr; 8(4):. PubMed ID: 30959852
[TBL] [Abstract][Full Text] [Related]
19. PD-1 does not mark tumor-infiltrating CD8+ T cell dysfunction in human gastric cancer.
Shen Y; Teng Y; Lv Y; Zhao Y; Qiu Y; Chen W; Wang L; Wang Y; Mao F; Cheng P; Ma D; Zhuang Y; Zou Q; Peng L
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32753468
[TBL] [Abstract][Full Text] [Related]
20. The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1.
Yi M; Zhang J; Li A; Niu M; Yan Y; Jiao Y; Luo S; Zhou P; Wu K
J Hematol Oncol; 2021 Feb; 14(1):27. PubMed ID: 33593403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
